Tevogen Bio Inc.

1.20
0.00 (0.00%)
At close: Mar 28, 2025, 3:59 PM
1.20
-0.02%
After-hours: Mar 28, 2025, 06:56 PM EDT
0.00%
Bid 1.14
Market Cap 210.06M
Revenue (ttm) n/a
Net Income (ttm) -5.26M
EPS (ttm) 0.35
PE Ratio (ttm) 3.43
Forward PE n/a
Analyst Buy
Ask 1.2
Volume 175,565
Avg. Volume (20D) 2,110,935
Open 1.22
Previous Close 1.20
Day's Range 1.18 - 1.22
52-Week Range 0.26 - 4.78
Beta -1.05

About TVGN

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey....

Industry Biotechnology
Sector Healthcare
IPO Date Jan 5, 2022
Employees 17
Stock Exchange NASDAQ
Ticker Symbol TVGN
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for TVGN stock is "Buy." The 12-month stock price forecast is $10, which is an increase of 733.33% from the latest price.

Stock Forecasts
3 weeks ago
+7.63%
Tevogen Bio Holdings shares are trading higher aft... Unlock content with Pro Subscription
2 months ago
+24.44%
Tevogen Bio shares are trading higher after the company announced an AI collaboration with Microsoft.